"Lewis X Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A trisaccharide antigen expressed on glycolipids and many cell-surface glycoproteins. In the blood the antigen is found on the surface of NEUTROPHILS; EOSINOPHILS; and MONOCYTES. In addition, Lewis X antigen is a stage-specific embryonic antigen.
| Descriptor ID |
D016256
|
| MeSH Number(s) |
D23.050.285.050.050 D23.050.301.264.900.050 D23.050.301.264.965.500 D23.050.301.290.544.059 D23.050.550.325.050 D23.050.705.230.544.059 D23.101.100.900.050 D23.101.140.075.050
|
| Concept/Terms |
Lewis X Antigen- Lewis X Antigen
- Antigen, Lewis X
- X Antigen, Lewis
- CD15 Antigen
- CD15 Antigens
- Antigens, CD15
- Lewis X Hapten
- X Hapten, Lewis
- Hapten X
- 3 alpha-Fucosyl-N-Acetyl Lactosamine
- 3 alpha Fucosyl N Acetyl Lactosamine
- Leu-M1 Antigens
- Leu M1 Antigens
- SSEA-1
- SSEA-1 Determinant
- SSEA 1 Determinant
- Stage-Specific Embryonic Antigen-1
- Embryonic Antigen-1, Stage-Specific
- Stage Specific Embryonic Antigen 1
- Le(X) Antigen
- Galbeta(1-4)Fucalpha(1-3)GlcNAc
- SSEA 1
|
Below are MeSH descriptors whose meaning is more general than "Lewis X Antigen".
- Chemicals and Drugs [D]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Neoplasm [D23.050.285]
- Antigens, Tumor-Associated, Carbohydrate [D23.050.285.050]
- Lewis X Antigen [D23.050.285.050.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, Myelomonocytic [D23.050.301.264.900]
- Lewis X Antigen [D23.050.301.264.900.050]
- Stage-Specific Embryonic Antigens [D23.050.301.264.965]
- Lewis X Antigen [D23.050.301.264.965.500]
- Blood Group Antigens [D23.050.301.290]
- Lewis Blood-Group System [D23.050.301.290.544]
- Lewis X Antigen [D23.050.301.290.544.059]
- Epitopes [D23.050.550]
- Antigens, Tumor-Associated, Carbohydrate [D23.050.550.325]
- Lewis X Antigen [D23.050.550.325.050]
- Isoantigens [D23.050.705]
- Blood Group Antigens [D23.050.705.230]
- Lewis Blood-Group System [D23.050.705.230.544]
- Lewis X Antigen [D23.050.705.230.544.059]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, Myelomonocytic [D23.101.100.900]
- Lewis X Antigen [D23.101.100.900.050]
- Biomarkers, Tumor [D23.101.140]
- Antigens, Tumor-Associated, Carbohydrate [D23.101.140.075]
- Lewis X Antigen [D23.101.140.075.050]
Below are MeSH descriptors whose meaning is more specific than "Lewis X Antigen".
This graph shows the total number of publications written about "Lewis X Antigen" by people in this website by year, and whether "Lewis X Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 0 | 3 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lewis X Antigen" by people in Profiles.
-
Prosniak M, Kenyon LC, Hooper DC. Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells. J Neuropathol Exp Neurol. 2021 08 11; 80(7):674-684.
-
Gharbaran R, Goy A, Tanaka T, Park J, Kim C, Hasan N, Vemulapalli S, Sarojini S, Tuluc M, Nalley K, Bhattacharyya P, Pecora A, Suh KS. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients. J Hematol Oncol. 2013 Aug 29; 6:62.
-
Kotsakis A, Harasymczuk M, Schilling B, Georgoulias V, Argiris A, Whiteside TL. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J Immunol Methods. 2012 Jul 31; 381(1-2):14-22.
-
Huang LT, Paredes CJ, Papoutsakis ET, Miller WM. Gene expression analysis illuminates the transcriptional programs underlying the functional activity of ex vivo-expanded granulocytes. Physiol Genomics. 2007 Sep 19; 31(1):114-25.
-
Miettinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol. 2001 May; 25(5):610-7.
-
Thakur ML, Marcus CS, Kipper SL, Ahdoot R, Diggles L, Pham HL, Minami C, Patel MC, Smith T. Imaging infection with LeuTech. Nucl Med Commun. 2001 May; 22(5):513-9.
-
Hevehan DL, Wenning LA, Miller WM, Papoutsakis ET. Dynamic model of ex vivo granulocytic kinetics to examine the effects of oxygen tension, pH, and interleukin-3. Exp Hematol. 2000 Sep; 28(9):1016-28.
-
Rodgers SD, Camphausen RT, Hammer DA. Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin. Biophys J. 2000 Aug; 79(2):694-706.
-
Zamai L, Secchiero P, Pierpaoli S, Bassini A, Papa S, Alnemri ES, Guidotti L, Vitale M, Zauli G. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood. 2000 Jun 15; 95(12):3716-24.
-
Mozley PD, Thakur ML, Alavi A, Smith T, Barraclough ED, Wilding P, Rhodes BA, Patel M, Mathur A, Li P. Effects of a 99mTc-labeled murine immunoglobulin M antibody to CD15 antigens on human granulocyte membranes in healthy volunteers. J Nucl Med. 1999 Dec; 40(12):2107-14.